Bookbuilding IPO | ₹77 Cr | Listed at NSE SME
KRM Ayurveda IPO is a book build issue of ₹77.49 crores. The issue is entirely a fresh issue of 0.57 crore shares of ₹77.49 crore.
KRM Ayurveda IPO bidding started from Jan 21, 2026 and ended on Jan 23, 2026. The allotment for KRM Ayurveda IPO was finalized on Jan 27, 2026. The shares got listed on NSE SME on Jan 29, 2026.
KRM Ayurveda IPO price band is set at ₹135 per share. The lot size for an application is 1,000. The minimum amount of investment required by an individual investor (retail) is ₹2,70,000 (2,000 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (3,000 shares), amounting to ₹4,05,000.
NEXGEN Financial Solutions Pvt. Ltd. is the book running lead manager and Skyline Financial Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company areNikunj Stock Brokers Ltd., Mansi Share & Stock Broking Pvt.Ltd..
Refer to KRM Ayurveda IPO RHP for detailed Information.
IPO Open
Wed, Jan 21, 2026
IPO Close
Fri, Jan 23, 2026
Issue Price
₹135 per share
Market Cap (Pre-IPO)
₹287.02 Cr
| IPO Date | 21 to 23 Jan, 2026 |
| Listed on | Thu, Jan 29, 2026 |
| Face Value | ₹10 per share |
| Price Band | ₹128 to ₹135 |
| Issue Price | ₹135 per share |
| Lot Size | 1,000 Shares |
| Sale Type | Fresh Capital |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 57,40,000 shares (agg. up to ₹77 Cr) |
| Reserved for Market Maker | 5,74,000 shares Mansi Share & Stock Broking Pvt.Ltd. (agg. up to ₹8 Cr) Nikunj Stock Brokers Ltd. |
| Net Offered to Public | 51,66,000 shares (agg. up to ₹70 Cr) |
| Share Holding Pre Issue | 1,55,20,800 shares |
| Share Holding Post Issue | 2,12,60,800 shares |
| NSE Symbol | KRMAYURVED |
| ISIN | INE1MTV01019 |
KRM Ayurveda IPO offers total 57,40,000 shares. Out of which 25,74,000 (44.84%) allocated to QIB, 10,32,000 (17.98%) allocated to QIB (Ex- Anchor), 7,80,000 (13.59%) allocated to NII 18,12,000 (31.57%) allocated to RII and 15,42,000 (26.86%) allocated to Anchor investors.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 5,74,000 (10.00%) |
| QIB Shares Offered | 25,74,000 (44.84%) |
| − Anchor Investor Shares Offered | 15,42,000 (26.86%) |
| − QIB (Ex. Anchor) Shares Offered | 10,32,000 (17.98%) |
| NII (HNI) Shares Offered | 7,80,000 (13.59%) |
| − bNII > ₹10L | 5,19,000 (9.04%) |
| − sNII < ₹10L | 2,61,000 (4.55%) |
| Retail Shares Offered | 18,12,000 (31.57%) |
| Total Shares Offered | 57,40,000 (100.00%) |
Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2,000 | ₹2,70,000 |
| Individual investors (Retail) (Max) | 2 | 2,000 | ₹2,70,000 |
| S-HNI (Min) | 3 | 3,000 | ₹4,05,000 |
| S-HNI (Max) | 7 | 7,000 | ₹9,45,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,80,000 |
KRM Ayurveda IPO raises ₹20.82 crore from anchor investors. KRM Ayurveda IPO Anchor bid date is January 20, 2026.
📝 Anchor Investors Letter (PDF)
| Bid Date | Tue, Jan 20, 2026 |
| Shares Offered | 15,42,000 |
| Anchor Portion (₹ Cr.) | 20.82 |
| Anchor lock-in period end date for 50% shares (30 Days) | Sat, Feb 21, 2026 |
| Anchor lock-in period end date for remaining shares (90 Days) | Wed, Apr 22, 2026 |
Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales.
They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care / wellness related items.
Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country.
Hospitals and Clinics are equipped with the following infrastructure & facilities:
Services:
As on December 31, 2025, the company have total of 443 employees operating under various departments.
Competitive Strengths:
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 78.12 | 66.79 | 43.91 | 39.48 |
| Total Income | 48.65 | 76.95 | 67.57 | 89.38 |
| Profit After Tax | 8.14 | 12.10 | 3.41 | 7.60 |
| EBITDA | 12.83 | 19.11 | 7.34 | 11.03 |
| NET Worth | 36.13 | 23.88 | 11.78 | 8.37 |
| Reserves and Surplus | 20.61 | 23.73 | 11.63 | 8.22 |
| Total Borrowing | 25.07 | 31.20 | 23.18 | 19.87 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Capital Expenditure for Construction and Development of Telemedicine Operational Facilities | 13.67 |
| 2 | Purchase of CRM Software and Hardware Infrastructure | 1.42 |
| 3 | Human Resources | 5.44 |
| 4 | Repayment/Prepayment of loan | 12.50 |
| 5 | Working Capital Requirement | 22.90 |
| 6 | General Corporate Purposes | 10.00 |
| KPI | Sep 30, 2025 | Mar 31, 2025 |
|---|---|---|
| ROE | 21.84% | 67.86% |
| ROCE | 21.84% | 43.33% |
| Debt/Equity | 0.69 | 1.31 |
| RoNW | 21.84% | 67.86% |
| PAT Margin | 16.83% | 15.80% |
| EBITDA Margin | 26.54% | 24.96% |
| Price to Book Value | 5.27 | 0.08 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 7.79 | 5.69 |
| P/E (x) | 17.32 | 23.73 |
| Promoter Holding | 92.16% | 67.28% |
| Market Cap | ₹287.02 Cr. |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Book Running Lead manager(s) Fees | 1.00 |
| 2 | Underwriting commission | 3.80 |
| 3 | Brokerage, Selling Commission and upload fees | 0.04 |
| 4 | Registrars to the issue | 0.02 |
| 5 | Legal Advisors | 0.03 |
| 6 | Advertising and Marketing Expenses | 0.05 |
| 7 | Regulators including stock exchanges | 0.10 |
| 8 | Printing and distributions of issue stationary | 0.03 |
| 9 | Others, if any (Market Maker fees, Peer Review Auditor, Selling and Distribution Expenses, Marketing Expenses and other misc. expenses) | 6.51 |
| Price Details | NSE SME |
|---|---|
| Final Issue Price | ₹135.00 |
| Open | ₹172.10 |
| Low | ₹165.15 |
| High | ₹180.70 |
| Last Trade | ₹180.70 |
Lead Manager Reports
KRM Ayurveda IPO is a SME IPO of 57,40,000 equity shares of the face value of ₹10 aggregating up to ₹77 Crores. The issue is priced at ₹135 per share. The minimum order quantity is 1000.
The IPO opens on Wed, Jan 21, 2026, and closes on Fri, Jan 23, 2026.
Skyline Financial Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in KRM Ayurveda IPO using UPI as a payment gateway. Zerodha customers can apply in KRM Ayurveda IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in KRM Ayurveda IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The KRM Ayurveda IPO opens on Wed, Jan 21, 2026 and closes on Fri, Jan 23, 2026.
KRM Ayurveda IPO lot size is 1000, and the minimum amount required for application is ₹2,70,000, with 2 lots being the minimum application size.
You can apply in KRM Ayurveda IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for KRM Ayurveda IPO will be done on Tuesday, January 27, 2026, and the allotted shares will be credited to your demat account by Wed, Jan 28, 2026. Check the KRM Ayurveda IPO allotment status.
The KRM Ayurveda IPO listing date is on Thu, Jan 29, 2026.
